Company intelligence / Profile preview

ShangPharma

Ownership: Private
Development stage: Commercial

Overview

ShangPharma provides integrated drug discovery and development services, including chemistry, biology, preclinical development, pharmaceutical development, and biologics R&D. It has achieved milestones in multiple oncology and immunology programs for global pharma clients. The company does not report its own clinical results as it operates as a service provider rather than a product developer.

Therapeutic areas: OncologyImmunologyOther
Modalities: Small moleculeMonoclonal antibodyBiologic
Industry: Contract Research Organization

Partnerships

Jiangsu Hengrui Medicine Co., Ltd.partnerships with major global pharmaceutical companies including top U.S.-based pharma firms for biologics R&D.

Beyond the preview

Go deeper on ShangPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ShangPharma.

Explore the full profile